Literature DB >> 21813156

The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.

Cassandra Graham1, Susan Chilton-MacNeill, Maria Zielenska, Gino R Somers.   

Abstract

Pediatric undifferentiated soft tissue sarcomas are a group of diagnostically challenging tumors. Recent studies have identified a subgroup of undifferentiated soft tissue sarcomas with primitive round to plump spindle cell morphology and a t(4;19)(q35;q13.1) translocation resulting in the expression of a CIC-DUX4 fusion transcript, including 2 tumors previously reported by our laboratory (Cancer Genet Cytogenet 2009;195:1). In the present study, reverse transcriptase polymerase chain reaction assays developed for both frozen and paraffin-based tissues were applied to a series of 19 pediatric undifferentiated soft tissue sarcomas using a combination of primer sets covering the CIC-DUX4 fusion transcript. Of the 19 undifferentiated soft tissue sarcomas, 16 had primitive round to plump spindle cell morphology, and 3 had pure spindle cell morphology. Three of the 16 undifferentiated soft tissue sarcomas with primitive round cell morphology were found to harbor the CIC-DUX4 fusion transcript by reverse transcriptase polymerase chain reaction. Automated DNA sequencing of the polymerase chain reaction products identified 2 distinct transcript variants. One CIC-DUX4-positive tumor showed membranous CD99 positivity, 2 showed focal S100 positivity, and 1 showed focal CD57 positivity. With the 2 previously reported cases, the total number of CIC-DUX4-positive primitive round cell sarcomas identified at our institution has been brought to 5 (28%) of 18. Given the consistent involvement of the CIC-DUX4 fusion in a subset of primitive round cell undifferentiated soft tissue sarcomas, these findings suggest a central role for the fusion transcript in such tumors. The current findings further define a novel genetic subset of pediatric primitive round cell sarcomas and provide an additional diagnostic tool for their characterization and diagnosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813156     DOI: 10.1016/j.humpath.2011.04.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  40 in total

1.  High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.

Authors:  Antoine Italiano; Yun Shao Sung; Lei Zhang; Samuel Singer; Robert G Maki; Jean-Michel Coindre; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

2.  Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas.

Authors:  Katja Specht; Lei Zhang; Yun-Shao Sung; Marisa Nucci; Sarah Dry; Sumathi Vaiyapuri; Gunther H S Richter; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

3.  Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes.

Authors:  Yuichi Yamada; Masaaki Kuda; Kenichi Kohashi; Hidetaka Yamamoto; Junkichi Takemoto; Takeaki Ishii; Kunio Iura; Akira Maekawa; Hirofumi Bekki; Takamichi Ito; Hiroshi Otsuka; Makoto Kuroda; Yumi Honda; Shinji Sumiyoshi; Takeshi Inoue; Naoe Kinoshita; Atsushi Nishida; Kyoko Yamashita; Ichiro Ito; Shizuo Komune; Tomoaki Taguchi; Yukihide Iwamoto; Yoshinao Oda
Journal:  Virchows Arch       Date:  2017-02-14       Impact factor: 4.064

4.  Undifferentiated "round" cell ("Ewing-like") sarcoma: not always so-round nor Ewing-like.

Authors:  Wei-Lien Wang; Alexander J Lazar
Journal:  Virchows Arch       Date:  2017-02-13       Impact factor: 4.064

Review 5.  Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.

Authors:  Khin Thway; Andrew L Folpe
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

6.  Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.

Authors:  Cristina R Antonescu; Adepitan A Owosho; Lei Zhang; Sonja Chen; Kemal Deniz; Joseph M Huryn; Yu-Chien Kao; Shih-Chiang Huang; Samuel Singer; William Tap; Inga-Marie Schaefer; Christopher D Fletcher
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

7.  Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.

Authors:  Lorena Lazo de la Vega; Daniel H Hovelson; Andi K Cani; Chia-Jen Liu; Jonathan B McHugh; David R Lucas; Dafydd G Thomas; Rajiv M Patel; Scott A Tomlins
Journal:  Hum Pathol       Date:  2016-09-21       Impact factor: 3.466

8.  Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Luis Rubio; Jorge Campos; María Barrios; Camille Grison; Virginie Chene; Gaelle Pierron; Olivier Delattre; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2013-11-10       Impact factor: 4.064

9.  ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.

Authors:  Sophie Le Guellec; Valérie Velasco; Gaëlle Pérot; Sarah Watson; Franck Tirode; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

10.  Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.

Authors:  Yin P Hung; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.